Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6288593 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP1A2TAAR1CYP3A4TDP1 | |
| SCHEMBL11664569 | 0.82 | TDP1 (0.53) | ALDH1A1CYP1A2CYP3A4TDP1HSD17B10 | |
| SCHEMBL230096 | 0.82 | TDP1 (0.53) | ALDH1A1CYP1A2CYP3A4TDP1HSD17B10 | |
| Phosphine SCHEMBL21463026 | 0.79 | TDP1 (0.50) | ALDH1A1CYP1A2CYP3A4TDP1CA1 | |
| SCHEMBL28788167 | 0.79 | TDP1 (0.50) | ALDH1A1CYP1A2CYP3A4TDP1CA1 | |
| SCHEMBL11655670 | 0.79 | TDP1 (0.50) | ALDH1A1CYP1A2CYP3A4TDP1CA1 | |
| SCHEMBL29009366 | 0.79 | TDP1 (0.50) | ALDH1A1CYP1A2CYP3A4TDP1CA1 | |
| SCHEMBL8035535 | 0.79 | ALDH1A1 (0.45) | ALDH1A1CYP1A2TAAR1CYP3A4TDP1 | |
| Biphenyl SCHEMBL27646937 | 0.78 | ALDH1A1 (0.69) | ALDH1A1CYP1A2TAAR1CYP3A4TDP1 | |
| SCHEMBL2606103 | 0.77 | MAOA (0.44) | ALDH1A1CYP1A2CYP3A4TDP1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4509515-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4700033-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4700031-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | LG CHEM, LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-4559921-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | LG CHEM, LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-4559921-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-05-28 | — | — | EP | disclosed |
| CN-119836425-A | Ligand compound, organic chromium compound, and catalyst composition comprising same | 株式会社LG化学 | 2025-04-15 | — | — | CN | disclosed |
| EP-4509515-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-02-19 | — | — | EP | disclosed |
| CN-119403812-A | Ligand compound, organic chromium compound, and catalyst composition containing same | 株式会社LG化学 | 2025-02-07 | — | — | CN | disclosed |
| CN-119365472-A | Ligand compound, organic chromium compound, and catalyst composition comprising same | 株式会社LG化学 | 2025-01-24 | — | — | CN | disclosed |
| CN-119173521-A | Ligand compound, organic chromium compound, and catalyst composition comprising same | 株式会社LG化学 | 2024-12-20 | — | — | CN | disclosed |
| WO-2024219842-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024219843-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024210470-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2024-10-10 | — | — | WO | disclosed |
| WO-2024071940-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2024-04-04 | — | — | WO | disclosed |
| US-6084133-A | REACTING A PHOSPHINE HALIDE WITH A METAL, THEN PROTONATION RESULTING DIORGANO-SUBSTITUTED METAL PHOSPHIDE; SIMPLIFICATION, NONTOXIC, EFFICIENCY | KANKYO KAGAKU CENTER CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | OXER1, ORC3, CRKL | ALDH1A1 3554/4885CYP1A2 854/4885TAAR1 312/4885 |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | EXOC1, OXER1, ORC3 | ALDH1A1 3116/4885CYP1A2 743/4885TAAR1 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.